 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Study Finds Roche's NGS-Based HIV Assay Comparable to TruGene; Company Expects 2014 CE-IVD Approval
January 30, 2013
Study Finds Roche's NGS-Based HIV Assay Comparable to TruGene; Company Expects 2014 CE-IVD Approval
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People in the News: Dan Zabrowski, Thomas Schinecker, Charles Dadswell
April 24, 2013 / Clinical Sequencing News - Quest Publishes Validation Study of HIV Tropism Test Combining 454 and Sanger Sequencing
October 10, 2012 / Clinical Sequencing News - IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
September 12, 2012 / Clinical Sequencing News - Quest Evaluates NGS for Dx; First Entry is Sequencing-Based HIV Tropism Test
July 11, 2012 / Clinical Sequencing News - Sequencing-Based Tropism Testing for HIV May Be Feasible, if Not Yet Commercially Viable
May 24, 2011 / Clinical Sequencing News